Introduction
The importance of glycaemic control in the prevenIn the Diabetes Control and Complication Trial (DCCT) where patients were closely monitored, only tion of microvascular complications has been confirmed in both type 1 and type 2 diabetic patients.1,2 44% of patients in the intensively-treated group achieved the goal of a glycosylated haemoglobin However, achievement of optimal glycaemic control remains a major challenge to health-care providers.
∏6.05% at least once. Identification of factors that determine glycaemic control may help health-care profile including triglyceride (TG), total cholesterol (TC) and high-density cholesterol (HDL-C) as part of providers to manage these high-risk patients more effectively.
the routine assessment. An extra 10 ml of blood was taken for C-peptide and insulin measurement, with We examined the relationships between glycaemic control and some potential determining factors, with informed consent. Insulin resistance (IR) was estimated using the particular emphasis on therapeutic patient education, self-monitoring, treatment regimen, insulin resistance homeostasis model assessment (HOMA) as a product of FPG (mmol/l) and insulin concentration (mU/ml) and pancreatic b-cell function.
divided by 22.5.6 Insulin deficiency was defined as a fasting C-peptide ∏0.2 nmol/l.7,41 The use of insulin was considered to be appropriate in insulinMethods treated patients with a fasting plasma C-peptide ∏0.2 nmol/l or those with no insulin treatment with This was a cross-sectional study conducted in the regional diabetes clinic at the Prince of Wales C-peptide >0.2 nmol/l. Patients were considered to receive inappropriate treatment if they were not Hospital (PWH) of Hong Kong, a teaching hospital with a catchment population of 1.2 million, and treated with insulin but had a plasma C-peptide ∏0.2 nmol/l or were insulin-treated, but had a typical social class representation. A total of 562 consecutive newly-referred type 2 diabetic patients, plasma C-peptide >0.2 nmol/l. defined according to the 1985 WHO criteria,3 were studied during a 12-month period between January and December 1996. Patients with acute type 1
Laboratory assays
presentation, including diabetic ketoacidosis and heavy ketonuria were excluded. Classification of Plasma glucose was measured by a glucose oxidase method (Diagnostic Chemicals). HbA lc was measured diabetes was done by the authors, who were all endocrinologists, and was based on clinical presentaby an automated ion-exchange chromatographic method (Bio-Rad) (normal range 5.1-6.4%). Plasma tion, presence of ketonuria, and history of diabetic ketoacidosis. All patients were referred from clinics C-peptide was measured by radioimmunoassay (Novo Nordisk) with an intra-assay coefficient of in the community or other hospital clinics or were discharged from the hospital wards. Due to the lack variation (CV) of 3.4% and inter-assay CV of 9.6%. The lowest detection limit was 0.1 nmol/l. Insulin of a comprehensive health-care financing policy in Hong Kong, the majority of patients with chronic assay was performed using a radioimmunoassay kit (Pharmacia). The lower limit of detection was diseases were followed up at the low-cost public hospital clinics.
<2 mU/ml. The inter-assay CV was 5%. Total cholesterol and TG were measured enzymically in plasma Since 1993, the PWH Diabetes Centre has adopted the EuroDiab Database4 and designed a structured with commercial reagents (Dimension, Dupont Instrument). HDL-C was measured by the same assessment with data computation for all newlyreferred diabetic patients to streamline management. 5 enzymic assay after precipitation of the HDL-C by the heparin-manganese method. LDL-C was calcuDocumentation included demographic data, body weight and height, hip and waist circumferences, lated using Friedewald's equation.8 past medical history, tobacco and alcohol intake, previous education by dietitians and diabetes nurses, and methods of self-monitoring. Body mass index
Statistical analysis
was calculated as the weight (kg) divided by the square of the height (m). Waist5hip ratio was defined Statistical analysis was done using the Statistical Package for Social Sciences (SPSS) software. Plasma as waist circumference divided by hip circumference. Blood pressures were measured in both arms, triglyceride, C-peptide, insulin level and HOMA were logarithmically transformed due to skewed after the patients had rested for at least 5 min, with a mercury sphygmomanometer. The Korotkoff sound distributions. The Student's t-test and x2 tests were used for comparison between groups as appropriate. V was taken as the diastolic blood pressure. The mean of two readings measured 1 min apart was
Pearson's correlation analysis was used to examine the relationships between variables. Linear regression used. The higher reading in either arm was taken as the final reading.
and logistic regression analysis were used to examine the independent relationships amongst variables. All Patients were instructed to fast for at least 8 h and not to take any medication or insulin injections on results are expressed as means ±SD or geometric mean ×/[ antilog SD (for log-transformed data Figure 1 . Only 55.3% of patients had HbA lc referral, 70.5% (n=396) were on drug therapy (9% <8% upon referral, and a significant proportion of on insulin and 62.8% on oral agents), 20.6% (n= patients (22.8%) had very poor glycaemic control 116) were on diet and 9% (n=50) had not received with HbA lc >10%. 
Discussion
The DCCT and United Kingdom Prospective Diabetes Study (UKPDS) trials have settled the long-standing debate over the importance of glycaemic control on the development of microvascular complications in both type 1 and type 2 diabetes.1,2 Our prospective study in Chinese patients also found fasting plasma glucose to be an independent predictor for cardiovascular and renal deaths.9 There is also increasing evidence showing that chronic hyperglycaemia can cause direct tissue damage by altering intracellular viders lies in how to achieve optimal glycaemic control effectively. signalling pathways and endothelial functions.10,11 Despite this experimental and clinical evidence, the Type 2 diabetes is a heterogeneous disease with varying degrees of insulin resistance and deficiency.12 challenge faced by the majority of health-care pro-There is considerable overlap between type 1 and study in this respect was the dramatic reduction in leg amputation after education by a diabetes educator type 2 diabetes in clinical presentations, especially in some non-Caucasian populations.13,14 The large in a country hospital setting.15 Taken together, our findings suggest that patient education and self care number of exogenous and lifestyle factors which influence glycaemia often make optimal diabetes could have a beneficial effect on glycaemic control. Meal planning and dietary modifications are management difficult.14 Although the Prince of Wales Hospital is a regional important aspects of diabetes education.24 In type 1 diabetes, there were close associations between teaching hospital, the majority of patients are referred from the community for financial reasons rather than careful meal planning and HbA lc .27 Type 2 diabetic patients who had received dietary instructions also severity of disease. Due to the lack of a long-term health-care financing policy in Hong Kong, the showed an improvement in glycaemic control, irrespective of the methods of instruction.28 On the majority of people do not have medical insurance cover. As a result, patients with chronic diseases like other hand, type 2 diabetic patients who perceived absence of dietary recommendation had poor glycadiabetes, including those from the middle classes, often seek medical treatment in public hospital emic control.29 clinics where they pay a nominal fee.
In the present study involving 562 newly-referred
Self blood glucose monitoring (SBGM)
type 2 diabetic patients, the mean HbA lc was 8.4%. In the DCCT, the risk of diabetic complications
The continuous improvement in technology has made SBGM more user-friendly. Although early studincreased sharply once HbA lc rose beyond 8% and exponentially when it exceeded 10%.1 In this cohort, ies in the 70s supported the beneficial effects of SBGM on glycaemic control,30,31 these findings were 44.6% patients had HbA lc >8% and 22.8% had HbA lc >10%. Less than 31.1% of patients had HbA lc not always consistent.32-35 Some of these effects have been attributed to increased education and medical within the optimal range (<7%). Similar findings have been reported in other hospital-based studies care rather than SBGM itself.36 In the present study, HbA lc was 0.8% lower in patients who performed conducted in Western countries. [15] [16] [17] SBGM than in those who did not. Although this improvement might be related to other aspects of Therapeutic patient education diabetes education received during the process of teaching SBGM, it is conceivable that the feedback Therapeutic patient education and self care are essential for effective diabetes management.18, 19 In received during self monitoring further improved lifestyle modification. this cohort, only 35.7% of patients had seen a dietitian, 30.9% had seen a diabetes nurse, and only 25% of subjects performed SBGM. The majority of Insulin resistance and deficency these patients had received diabetes education either during hospital admissions or when they attended
In agreement with most studies,37,38 non-insulindeficient patients in the present study had features other hospital clinics before being referred to the Prince of Wales Hospital diabetes clinic. Nearly all resembling that of the metabolic syndrome. Increased plasma C peptide concentration was associated with patients newly referred from the community had not seen a dietitian or diabetes nurse before.
clustering of cardiovascular risk factors, including high blood pressure, obesity (central and general) A diabetes educator aims to modify patients' behavior by providing knowledge, changing attitude and dyslipidaemia characterized by low HDL-C and high triglycerides. and teaching skills with particular emphasis on self care. It can be a slow and painstaking process. 20 In Caucasians, 95% of type 2 diabetic patients are non-insulin-deficient.39 By contrast, as many as 21% Nevertheless, in the present study, we were able to demonstrate a correlation between therapeutic of these newly-referred Chinese type 2 diabetic patients had low plasma C peptide concentration patient education and SBGM, and glycaemic control. Non-smokers also had a lower HbA lc than smokers. suggesting insulin deficiency. Although insulin resistance is a feature of type 2 diabetes, insulin deficiency Tobacco has been shown to be a predictor for subsequent development of diabetes in middle-aged is an important factor in its pathogenesis.40 These findings are in accordance with our previous report men. 21 In both type 1 and type 2 patients, in-patient education programmes22 and outpatient counselling where 25% of a separate cohort of type 2 diabetic patients attending the diabetes clinic were treated improve glycaemic control,23-25 the more so in those who received intensive education programms.24 with insulin, despite only 3% having acute type 1 presentation. 16 In another cohort of young type 2 Simple educational tools such as flash cards have also been shown to be of benefit in Asian diabetic diabetic patients, we found a high prevalence of insulin deficiency41,42 but low prevalence of patients living in England. 26 The most impressive autoimmunity. Similar findings have also been found important factor contributing to poor glycaemic control, especially in the event of non-insulin therapy. in Chinese patients with classical type 1 presentation. 43 As in other studies,56 we found close associations between HOMA (a marker of insulin resistance), In Caucasians, the clinical mode of presentation often predicts the insulin status in diabetic patients, WHR and HbA lc in our Chinese patients with increased WHR contributing to poor glycaemic conalthough not without difficulty at times.44,45 Latent autoimmune diabetes in the adult,46 genetic causes40 trol. The other determinant of glycaemic control was duration of disease. Based on the UKPDS, the latter and disease duration29,47 all have effects on insulin secretory function. In the present study, increased is probably due to progressive deterioration in pancreatic b-cell function as shown in both type 157 BMI, triglycerides and diastolic blood pressure were the major predictors for a non-insulin-deficient state and type 2 diabetic patients.29,44,58 Furthermore, the UKPDS has shown that pancreatic b function failed in our logistic regression model. Other the other hand, based on plasma C-peptide, 21% of patients at an annual rate of 3-4% in type 2 diabetic patients, so that an increase in dosage of oral agents or had insulin deficiency, although only 9% were treated with insulin. More importantly, we found changeover to insulin treatment was required in the majority of type 2 patients.48 that patients receiving appropriate insulin treatment had better glycaemic control than those not receiving appropriate therapy. In the UKPDS, early use of Conclusions insulin in type 2 diabetic patients did not confer Our findings confirm the heterogeneity of pancreatic additional advantage over oral agents, but increased b-cell functions in Chinese type 2 diabetic patients. the risk of hypoglycaemia.48 Based on these findings, Long duration of disease, a low BMI (suggesting plasma C-peptide may be a useful indicator of insulin insulin deficiency), increased WHR (suggesting insusecretory function to optimize therapy. In this respect, lin resistance), lack of therapeutic patient education, fasting plasma C-peptide has been shown to predict inappropriate treatment in relation to pancreatic bfuture insulin requirement in type 2 patients. 39, 49 cell function and smoking habit were all independent Similarly, insulin therapy can be stopped in patients determinants for poor glycaemic control. We also who have adequate post-glucagon C-peptide demonstrated the potential beneficial effects of SBGM response.50,51
and education by a dietitian on glycaemic control in these patients.
Body mass index versus waist:hip ratio

